摘要
Abstract
OBJECTIVE: To evaluate the effectiveness and safety of puerarin vs. Venoruton for vertebrobasilar insufficiency (VBI). METHODS: Medline, Embase, SCI, CNKI, VIP, CBM and Wanfang database were searched, randomized controlled trials (RCT) of puerarin vs. Venoruton for VBI were included, quality evaluation and meta-analysis were carried out. RESULTS: 10 RCTs were gathered, graded C, Meta-analysis indicated the differences of total effective rate, blood viscosity and packed cell volume were significant: RR=[U4, 95%CI(1.09,1.20)],MD=[0.97,95%CI(0.68,1.27)],MD=[3.62,95%CI(1.08, 6.16)]. CONCLUSION: Based on current evidence, puerarin is better than venoruton in the treatment of VBI.关键词
葛根素/维脑路通/椎基底动脉供血不足/Meta分析Key words
Puerarin/Venoruton/Vertebrobasilar insufficiency/Meta-analysis分类
医药卫生
